Globe Life's Q4 2024 Earnings: What to Expect

Valued at a market cap of $9.5 billion, Globe Life Inc. (GL) provides various life and supplemental health insurance products, as well as annuities to lower middle- and middle-income families. The McKinney, Texas-based company is expected to announce its fiscal Q4 earnings results after the market closes on Wednesday, Feb. 5.

Prior to this event, analysts expect the insurance company to report a profit of $3.10 per share, up 10.7% from $2.80 per share in the year-ago quarter. The company has surpassed Wall Street's earnings estimates in three of the last four quarters while missing on another occasion. In Q3, GL’s adjusted EPS of $3.49 outpaced the forecasted figure by a significant margin of 14.4%. 

For fiscal 2024, analysts expect Globe Life to report an EPS of $12.32, up 15.7% from $10.65 in fiscal 2023.

www.barchart.com

Shares of GL have declined 6% over the past 52 weeks, massively underperforming both the S&P 500 Index's ($SPX22% rise and the Financial Select Sector SPDR Fund’s (XLF26.8% return over the same time frame.

www.barchart.com

The main reason behind Globe Life's underperformance last year is a report released in April that alleged that the company had engaged in misconduct and fraud. Shares of GL plunged 1.3% after its Q3 earnings release on Oct. 23 as the company’s revenues of $1.5 billion, which increased 5% from the year-ago quarter, slightly missed the Wall Street estimates. On the other hand, its adjusted EPS of $3.49 climbed 28.8% year-over-year and surpassed the estimates by a notable 14.4%.   

Wall Street analysts are moderately optimistic about GL’s stock, with a "Moderate Buy" rating overall. Among 11 analysts covering the stock, seven recommend a "Strong Buy," one suggests a “Moderate Buy,” and three indicate “Hold.” This configuration is slightly more bullish than three months ago, with six analysts suggesting a “Strong Buy.”

The average price target for GL is $133.36, which indicates an 18.1% potential upside from the current levels.

On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here. More news from Barchart

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.